Last 24 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.76 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.73 | 2.17 | 4.22 | 2.90 | 3.59 | 2.82 | 6.41 | 4.67 | 3.75 | 5.49 | 8.97 | 14.48 | 7.51 | 8.42 | 6.04 | 13.16 | 7.76 | 6.12 | 7.51 | 17.02 | 24.51 |
| — | -23.1% | -34.1% | -37.7% | -4.2% | -48.6% | -28.6% | -67.8% | -50.0% | -34.8% | +48.5% | +10.0% | -3.3% | +37.4% | -19.6% | -22.7% | -68.3% | +646.3% | — | — | — | |
| P/B Ratio | 1.03 | 6.83 | 8.57 | 4.73 | 4.39 | 2.65 | 4.56 | 4.03 | 3.08 | 4.69 | 5.84 | 8.62 | 3.81 | 3.55 | 1.94 | 3.46 | 1.62 | 0.97 | 0.90 | 1.71 | 2.14 |
| — | +158.1% | +87.7% | +17.5% | +42.7% | -43.6% | -21.8% | -53.3% | -19.2% | +32.0% | +201.5% | +149.1% | +134.7% | +266.7% | +116.1% | +102.8% | -24.0% | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.3% | 87.4% | 87.2% | 86.3% | 85.5% | 82.8% | 83.5% | 85.0% | 83.2% | 82.7% | 83.8% | 84.8% | 83.9% | 84.0% | 83.4% | 79.0% | 78.3% | 76.1% | 76.7% | 73.1% | 74.2% |
| — | +5.5% | +4.4% | +1.5% | +2.8% | +0.2% | -0.3% | +0.3% | -0.9% | -1.6% | +0.5% | +7.4% | +7.1% | +10.4% | +8.7% | +8.0% | +5.6% | +7.6% | +10.1% | -6.8% | -0.9% | |
| Operating Margin | -90.5% | -82.9% | -82.3% | -69.8% | -83.5% | -105.8% | -108.8% | -67.0% | -97.3% | -118.3% | -206.4% | -85.5% | -90.6% | -123.7% | -152.4% | -160.0% | -163.7% | -218.9% | -243.1% | -240.2% | -214.8% |
| — | +21.6% | +24.3% | -4.2% | +14.2% | +10.6% | +47.3% | +21.6% | -7.3% | +4.3% | -35.4% | +46.6% | +44.6% | +43.5% | +37.3% | +33.4% | +23.8% | -20.5% | -64.9% | -135.0% | -12.6% | |
| Net Margin | -94.1% | -89.4% | -88.8% | -74.5% | -87.6% | -108.4% | -111.5% | -69.4% | -98.0% | -118.8% | -206.0% | -81.1% | -85.7% | -122.6% | -142.5% | -146.8% | -158.9% | -220.1% | -245.1% | -289.0% | -180.6% |
| — | +17.5% | +20.3% | -7.3% | +10.6% | +8.7% | +45.9% | +14.3% | -14.3% | +3.1% | -44.5% | +44.8% | +46.1% | +44.3% | +41.8% | +49.2% | +12.0% | +61.3% | +18.7% | -77.3% | +18.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -96.6% | -57.3% | -38.3% | -27.3% | -24.3% | -23.2% | -19.6% | -15.6% | -21.8% | -23.1% | -31.2% | -11.5% | -10.4% | -12.3% | -10.9% | -9.3% | -8.0% | -8.4% | -7.1% | -7.0% | -3.9% |
| — | -147.3% | -95.6% | -74.7% | -11.6% | -0.3% | +37.2% | -35.5% | -108.6% | -87.9% | -186.4% | -24.6% | -30.2% | -46.5% | -54.2% | -32.2% | -103.5% | — | — | — | +99.0% | |
| ROA | -44.8% | -14.6% | -12.8% | -11.0% | -11.1% | -11.8% | -10.5% | -8.2% | -11.7% | -13.9% | -20.0% | -8.3% | -8.1% | -9.8% | -9.2% | -8.4% | -7.5% | -8.0% | -6.7% | -6.3% | -5.2% |
| — | -23.7% | -22.6% | -35.4% | +4.8% | +14.8% | +47.8% | +1.3% | -43.9% | -41.6% | -118.2% | +1.3% | -7.9% | -23.3% | -36.5% | -32.5% | -45.6% | +74.2% | +51.2% | -20.4% | — | |
| ROIC | -256.7% | -63.9% | -59.6% | -60.2% | -68.4% | -70.5% | -61.7% | -49.7% | -63.2% | -65.1% | -101.9% | -46.4% | -48.0% | -69.4% | -87.1% | -92.0% | -101.8% | -133.2% | -148.2% | -160.3% | -126.1% |
| — | +9.5% | +3.4% | -21.2% | -8.3% | -8.3% | +39.4% | -7.0% | -31.5% | +6.2% | -16.9% | +49.5% | +52.8% | +47.9% | +41.2% | +42.6% | +19.3% | — | — | — | -1269.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.29 | 2.96 | 2.04 | 1.29 | 1.05 | 0.87 | 0.73 | 0.71 | 0.77 | 0.55 | 0.46 | 0.40 | 0.19 | 0.17 | 0.15 | 0.06 | 0.00 | 0.00 | 0.00 | — | 0.13 |
| — | +239.0% | +180.7% | +82.0% | +35.9% | +57.6% | +57.4% | +76.1% | +316.7% | +223.8% | +217.3% | +521.1% | +5486.3% | +4605.6% | +3788.9% | — | -97.3% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 7.63 | 8.04 | 10.20 | 7.63 | 9.62 | 11.99 | 14.83 | 12.06 | 11.32 | 10.08 | 12.18 | 14.25 | 13.99 | 12.55 | 15.15 | 15.19 | 16.82 | 22.33 | 21.57 | 25.57 | 20.42 |
| — | -32.9% | -31.2% | -36.7% | -15.0% | +18.9% | +21.7% | -15.4% | -19.1% | -19.7% | -19.6% | -6.2% | -16.9% | -43.8% | -29.7% | -40.6% | -17.6% | +931.4% | +330.5% | +217.1% | — | |
| Quick Ratio | 6.72 | 6.87 | 8.89 | 6.72 | 8.60 | 10.78 | 13.45 | 10.94 | 10.23 | 8.85 | 10.87 | 12.86 | 12.52 | 11.33 | 14.12 | 14.33 | 16.00 | 21.34 | 20.77 | 24.92 | 20.03 |
| — | -36.2% | -33.9% | -38.6% | -15.9% | +21.8% | +23.8% | -14.9% | -18.3% | -21.9% | -23.0% | -10.3% | -21.8% | -46.9% | -32.0% | -42.5% | -20.1% | +946.8% | +336.7% | +225.9% | — | |
| Interest Coverage | -8.15 | -7.90 | -7.46 | -7.43 | -7.70 | -9.01 | -8.45 | -6.05 | -12.62 | -13.59 | -22.07 | -14.76 | -16.98 | -23.15 | -46.25 | -62.68 | — | — | — | -25.63 | -8.95 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CVRX stock.
CVRx, Inc.'s current P/E is -0.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
CVRx, Inc.'s current operating margin is -90.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CVRx, Inc.'s business trajectory between earnings reports.